Documents | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Documents

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Document Type

  • Publication (141)
  • Testimony (88)
  • Microgram (49)
  • Speech (21)
  • Announcements (3)
  • In the News (1)
  • DEA Administrator Remarks (27)

Publication Type

  • DEA Administrator (27)

Drug Name

  • Fentanyl (5)
  • Narcotics (Opioids) (4)
  • Drugs of Concern (1)
  • Ketamine (1)
  • Methamphetamine (1)
  • Synthetic Opioids (1)
  • Xylazine (1)
Clear All Results
DOCUMENT

Administrator Anne Milgram Delivers Opening Statement Before the House Committee on Appropriations Commerce, Justice, Science Subcommittee

May 07, 2024
DEA Administrator Remarks
"I want to thank the Subcommittee for inviting me to testify today on National Fentanyl Awareness Day. It is appropriate that on National Fentanyl Awareness Day, that I am given the opportunity to highlight for you the national tragedy that is being caused by fentanyl. According to the CDC, in...
May 07, 2024
DOCUMENT

Statement from DEA Administrator Anne Milgram on the Increase in DEA Fentanyl Seizures Containing Xylazine

April 26, 2024
DEA Administrator Remarks
WASHINGTON – DEA first warned the public of a sharp increase in fentanyl seizures containing xylazine in our March 2023 Public Safety Alert . Since that time, xylazine’s growing prevalence in the fentanyl supply continues to make the deadliest drug threat facing this country even deadlier. In 2023, 30% of...
April 26, 2024
DOCUMENT

Operation Blues Brothers

November 22, 2023
DEA Administrator Remarks
U.S. Attorney’s Office, District of Columbia Press Conference - November 20, 2023 Fentanyl is the greatest threat to Americans today. It is devastating families across our country and killing Americans from all walks of life. And it is the leading cause of death for Americans between the ages of 18...
November 22, 2023
DOCUMENT

Statement by the Administrator on DEA’s Settlement Agreement with Truepill Pharmacy

November 06, 2023
DEA Administrator Remarks
DEA is steadfastly committed to ensuring that all Americans get access to needed medications, while also ensuring patient safety. Stimulants are important medications for both children and adults. They are also Schedule II controlled substances that can be highly addictive and that require the greatest care in prescribing. When inappropriately...
November 06, 2023
DOCUMENT

Update on the Prescription Stimulant Shortage

November 01, 2023
DEA Administrator Remarks
Dear Americans, On August 1, 2023, I wrote to you with FDA Commissioner Robert Califf to address the lack of availability of certain prescription stimulant medications. As we said then, the U.S. Food and Drug Administration (FDA)and the Drug Enforcement Administration (DEA) recognize the important role that prescription stimulants play...
November 01, 2023
DOCUMENT

Justice Department Announces Eight Indictments Against China Based Chemical Manufacturing Companies and Employees

October 03, 2023
DEA Administrator Remarks
“Fentanyl is the deadliest drug threat our nation has ever faced. These eight cases are the result of DEA’s efforts to attack the fentanyl supply chain where it starts — in China. Chinese chemical companies are fueling the fentanyl crisis in the United States by sending fentanyl precursors, fentanyl analogues...
October 03, 2023
DOCUMENT

Statement of Anne Milgram Administrator at a Hearing Entitled Oversight of the Drug Enforcement Administration

July 27, 2023
DEA Administrator Remarks
Chair Biggs, Ranking Member Jackson Lee, and distinguished members of the subcommittee: On behalf of the Department of Justice (Department), and in particular the nearly 10,000 employees working at the Drug Enforcement Administration (DEA), thank you for the opportunity to appear before you today to discuss DEA’s work to save...
July 27, 2023
DOCUMENT

DEA Administrator's Remarks on China-Based Chemical Manufacturing Companies and Arrests

June 23, 2023
DEA Administrator Remarks
“Today’s announcement is a considerable step forward in our unrelenting fight against fentanyl, targeting the threat where it starts. These companies and individuals are alleged to have knowingly supplied drug traffickers, in the United States and Mexico, with the ingredients and scientific know-how needed to make fentanyl – a drug...
June 23, 2023
DOCUMENT

Statement from the DEA Administrator Anne Milgram on COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications

May 03, 2023
DEA Administrator Remarks
The Drug Enforcement Administration received a record 38,000 comments on its proposed telemedicine rules. We take those comments seriously and are considering them carefully. We recognize the importance of telemedicine in providing Americans with access to needed medications, and we have decided to extend the current flexibilities while we work...
May 03, 2023
DOCUMENT

DOJ and DEA Announce Charges against Chapitos

April 14, 2023
DEA Administrator Remarks
“Today’s indictments send a clear message to the Chapitos, the Sinaloa Cartel, and criminal drug networks around the world that the DEA will stop at nothing to protect the national security of the United States and the safety and health of the American people,” said DEA Administrator Anne Milgram. “The...
April 14, 2023
Showing 11 - 20 of 27 results

Pagination

  • First page «
  • Previous page ‹
  • Page 1
  • Current page 2
  • Page 3
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster